The trauma patient presents several challenges in areas of anticoagulation and haemostasis. Low molecular weight heparins are the mainstay of thrombopro phylaxis of trauma patients; however, new agents are being studied in trials and may soon be available. Patients already on oral anticoagulation may need reversal using plasma or prothrombin complex concentrates. Heparin-induced thrombo cytopenia needs a high index of suspicion and prompt treatment by clinicians treating trauma patients. Disseminated intravascular coagulation can be seen in the context of major trauma. Correction of the underlying cause and supportive blood component use are the mainstays of treatment.
Alving B.2003. How I treat heparin-induced thrombocytopenia and thrombosis. Blood101: 31-37
2.
Bauer KA, Erikson BI, Lassen MR, Turpie AGG.2001. Fondaparinux compared with Enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med345: 1305-1310.
3.
Bernard GR, Vincent JL, Laterre PFet al.2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med344: 699-709.
4.
British Committee for Standards in Haematology. 1998. Guidelines on oral anticoagulation. 3rd edition. Br J Haematol101: 374-387.
5.
Cartmill M, Dolan G, Byrne JL, Byrne PO.2000. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg14: 458-461.
6.
Danhof M, deBoer A, Magnani HN, Stiekame JC.1992. Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Hemostasis. 22: 73-84.
7.
Dennis JW, Menawat S, Von Thron Jet al.1993. Efficacy of deep venous prophylaxis in trauma patients and identification of high-risk groups. J Trauma35: 132-139
8.
Eriksson BI, Bauer KA, Lassen MR, Turpie AGG.2001. Fondaparinux compared with Enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med345: 1298-1304.
9.
Eriksson BI, Bergquist D, Kalebo Pet al.2002. Ximelagatran and Melagatran compared with dalteparin for prevention of venous thromboembolism after total hip replacement: the METHRO II randomized trial. Lancet360: 1441-1447.
10.
Eriksson BI, Agnelli G, Cohen ATet al. (METHRO III study group). 2003. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparision with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost89: 288-296.
11.
Geerts WH, Code KI, Jay RMet al.1994. A prospective study of venous thromboembolism after major trauma. N Engl J Med331: 1601-1606.
12.
Geerts WH, Jay RM, Code KIet al.1996. A comparision of low-dose heparin with low-molecular-weight heparin as prophylaxis against VTE after major trauma. N Engl J Med335: 701-707.
13.
Greinacher A, Eichler P, Lubenow Net al.2000. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood96: 846-851
Huhle G, Hoffmann U, Song Xet al.1999. Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment. Br J Haematol106: 195-201.
16.
Karni A, Holtzman R, Bass Tet al.2001. Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg67: 1098-1100.
17.
Kessler C.2002. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?Intens Care Med28(Suppl 2): S228-S234.
18.
Knudson MM, Lewis FR, Clinton Aet al.1994. Prevention of venous thromboembolism in trauma patients. J Trauma37: 480-487
19.
Li J, Brown J, Levine M.2001. Mild head injury, anticoagulants and risk of intracranial injury. Lancet357: 771-772.
20.
Meissner MH.1998. Deep venous thrombosis in the trauma patient. Semin Vasc Surg11: 274-282.
21.
Mina AA, Bair HA, Howells GA, Bendick PJ.2003. Complications of pre-injury warfarin use in the trauma patient. J Trauma54: 842-847.
22.
Park P, Fewel ME, Thompson BG, Hoff JT.2003. Recombinant activated factor VII for rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery53: 34-38.
23.
Preston FE, Laidlaw ST, Sampson B, Kitchen S.2002. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol116: 619-624.
24.
Rogers FB, Cipolle MD, Velmahos Get al.2002. Practice Management Guidelines for the prevention of venous thromboembolism in trauma patients: The EAST Practice management guidelines Work Group. J Trauma53: 142-164.
25.
Schwarcz TH, Quick RC, Minion DJet al.2001. Enoxaparin treatment in high-risk trauma patients limits the utility of surveillance venous duplex scanning. J Vasc Surg34: 447-452.
26.
Shackford SR, Davis JW, Hollingsworth-Fridlund Pet al.1990. Venous thromboembolism in patients with major trauma. Am J Surg159: 365-369.
27.
Sharpe RP, Gupta R, Gracias VHet al.2002. Incidence and natural history of below-knee deep venous thrombosis in high-risk trauma patients. J Trauma53: 1048-1052.
28.
Spain DA, Bergamini JM, Hoffmann JFet al.1998. Comparison of sequential compression devices and foot pumps for prophylaxis of deep venous thrombosis in high-risk trauma patients. Am Surg64: 522-526.
29.
Turpie AG, Bauer KA, Eriksson BI, Lassen MR.2002a. Post operative Fondaparinux versus post operative Enoxaparin for the prevention of venous thromboembolism after elective hip replacement surgery: a randomized double blind trial. Lancet359: 1721-1726.
30.
Turpie AG, Eriksson BI, Lassen MRet al.2002b. A meta-analysis of fondaparinux versus enoxaparin in prevention of venous thromboembolism after major orthopaedic surgery. J South Orthop Assoc11: 182-188.
31.
Upchurch GR Jr, Demling RH, Davies Jet al.1995. Efficacy of subcutaneous heparin in prevention of venous thromboembolic events in trauma patients. Am Surg61: 749-755.
32.
Velmahos GC, Kern J, Chan LSet al.2000. Prevention of venous thrombo-embolism after trauma: an evidence-based report - part II: analysis of risk factors and evaluation of the role of vena cava filters. J Trauma49: 140-144.
33.
Veshchev I, Elran H, Salame K.2002. Recombinant coagulation factor VIIa for rapid preoperative correstionof warfarin-relatedcoagulopathyinpatients with acute subdural hematoma. Med Sci Monit8: CS98-CS100.
34.
Warkentin TE, Kelton JG.2001. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med344: 1286-1292.
35.
Wheeler HB, Anderson FA Jr.1993. Use of non-invasive tests as the basis for treatment of deep vein thrombosis. In: Bernstein EF ed. Vascular diagnosis, 4th ed.St Louis: Mosby; 1894-1912.
36.
Wheeler HB, Anderson FA Jr.1995. Diagnostic methods for deep vein thrombosis. Haemostasis25: 6-26.
